A joint publication of BMC, part of Springer Nature, and the Editorial Group of Molecular Brain since 2008.
Molecular Brain is affiliated with the Association for the Study of Neurons and Disease (AND).
Page 30 of 30
Calpastatin is an endogenous inhibitor of calpain, intracellular calcium-activated protease. It has been suggested to be involved in molecular mechanisms of long-term plasticity and excitotoxic pathways. Howev...
Elucidating the neural and genetic factors underlying psychiatric illness is hampered by current methods of clinical diagnosis. The identification and investigation of clinical endophenotypes may be one soluti...
Using an endophenotype-driven screen, a new study finds that α-calcium/calmodulin kinase II mutant mice exhibit a range of behavioral abnormalities related to schizophrenia. Perhaps most strikingly, this clust...
Diurnal rhythm-mediated endogenous cortisol levels in humans are characterised by a peak in secretion after awakening that declines throughout the day to an evening trough. However, a significant proportion of...
Whereas the induction of short-term memory involves only covalent modifications of constitutively expressed preexisting proteins, the formation of long-term memory requires gene expression, new RNA, and new pr...
Morphine is widely used to treat chronic pain, however its utility is hindered by the development of tolerance to its analgesic effects. While N-methyl-D-aspartate (NMDA) receptors are known to play roles in m...
We are delighted to announce the arrival of a brand new journal dedicated to the ever-expanding field of neuroscience. Molecular Brain is a peer-reviewed, open-access online journal that aims at publishing high q...
A joint publication of BMC, part of Springer Nature, and the Editorial Group of Molecular Brain since 2008.
Molecular Brain is affiliated with the Association for the Study of Neurons and Disease (AND).
Citation Impact 2023
Journal Impact Factor: 3.3
5-year Journal Impact Factor: 3.8
Source Normalized Impact per Paper (SNIP): 0.844
SCImago Journal Rank (SJR): 1.315
Speed 2024
Submission to first editorial decision (median days): 15
Submission to acceptance (median days): 88
Usage 2024
Downloads: 993,076
Altmetric mentions: 429
Molecular Brain has partnered with Publons to give you official recognition for your contribution to peer review. Create a free profile to have your reviews automatically added.